EVALUATING THE USEFULNESS OF SELF-SCORING AFTER DISCUSSING ANSWERS WITH 3RD YEAR MBBS PHARMACOLOGY STUDENTS.
http://doi.org/10.46536/jpumhs/2023/13.01.397
Keywords:
Key words: Self-scoring, MBBS, PharmacologyAbstract
Abstract
Introduction: Students may only utilise the idea of self-evaluate when they are able to choose the
standards that will be applied and make assessments about the extent to which their work satisfies those
standards. Methods: The present study was conducted at Suleman Roshan Medical College Tando Adam,
after the approval from institutional ethics review committee, from January 2022 to December 2022.
During the course of an entire year, Eleven separate tests, comprising 2 midterms, have already been
given. Following the final test, the pupils were provided with a Likert question asking them to contrast the
new assessment format with old one in terms of its academic potential & ability to assess their
competence. As well, the pupils were tasked with assessing the test's difficulty level, relevancy, &
duration. Results: A total of n=82 participants had submitted the responses on evaluating the usefulness
of self-scoring after discussing answers with 3rd year MBBS Pharmacology students. The responses were
obtained by likert Scale. Analysis of the findings had revealed that majority of the participants had either
strongly agree and agree with the questions regarding evaluating the usefulness of self-scoring after
discussion thus suggesting the fact 3rd year MBBS students were favouring the concept of self-scoring.
Results were analysed using P-value of ≤ 0.05(95% CI) as significant. Conclusion: It has always been
discovered that learners view this type of exam as a far more useful educational instrument than the
traditional one. The students are given real - time feedback, were made aware of one‘s wrong responses &
gaps in knowledge, & given the chance to think about them.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.